Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A -rearranged acute lymphoblastic leukemia: Children's Oncology Gr... by Guest, Erin M, Kairalla, John A, Devidas, Meenakshi, Hibbitts, Emily, Carroll, Andrew J, Heerema, Nyla A, Kubaney, Holly R, August, Margaret A, Ramesh, Sidharth, Yoo, Byunggil, Farooqi, Midhat S, Pauly, Melinda G, Wechsler, Daniel S, Miles, Rodney R, Reid, Joel M, Kihei, Cynthia D, Gore, Lia, Raetz, Elizabeth A, Hunger, Stephen P, Loh, Mignon L, Brown, Patrick A

Get full text

Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Childre... by Rau, Rachel E., Gupta, Sumit, Kairalla, John A., Rabin, Karen R, Angiolillo, Anne, Wang, Cindy, Carroll, Andrew J., Conway, Susan, Devidas, Meenakshi, Gore, Lia, Kirsch, Ilan R., Kubaney, Holly R., Li, Amanda M, McNeer, Jennifer L., Militano, Olga, Moyer, Yvonne, O'Brien, Maureen M., Okada, Maki, Reshmi, Shalini C., Shago, Mary, Wagner, Elizabeth R., Winick, Naomi J., Wood, Brent L., Zaman, Faraz, Zugmaier, Gerhard, Zupanec, Sue, Hunger, Stephen P., Teachey, David T., Raetz, Elizabeth A., Loh, Mignon L.

Get full text

A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Ch... by Guest, Erin, Kairalla, John, Devidas, Meenakshi, Hibbitts, Emily, Carroll, Andrew J., Heerema, Nyla A., Kubaney, Holly, August, Amanda, Pauly, Melinda, Wechsler, Daniel, Miles, Rodney R., Reid, Joel M., Kihei, Cynthia, Gore, Lia, Raetz, Elizabeth A., Hunger, Stephen P., Loh, Mignon L., Brown, Patrick A.

Get full text